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Abstract
Introduction: Obtaining suitable results unaffected by pre- or postanalytical phases is pivotal for clinical chemistry service. We aimed comparison 
and stability of nine biochemical analytes after centrifugation using Barricor™ plasma tubes with mechanical separator vs standard Vacutainer® 
lithium heparin tubes.
Materials and methods: We collected samples on six healthy volunteers and nine patients from intensive care units into 6 mL plastic Vacutainer® 
lithium heparin tubes and 5.5 mL plastic Barricor™ plasma tubes. All tubes were centrifuged within 30 minutes after venipuncture. First, we compa-
red results of nine biochemical analytes from lithium heparin tubes with Barricor™ tubes for each analyte using Passing-Bablok and Bland-Altman 
analyses. Second, we calculated the difference of analyte concentrations between baseline and time intervals in tubes stored at + 4 °C. Based on the 
total change limit we calculated the maximum allowable concentrations percentage change from baseline.
Results: The majority of correlation coefficients were close to 0.99 indicating good correlation in the working range. Bland-Altman analyses showed 
an acceptable concordance for all analytes. In consequence, the Barricor™ tube might be an alternative to regular lithium heparin tube. Stability with 
this new generation tube is improved for eight analytes (except for aspartate aminotransferase) in comparison with regular lithium heparin tubes. 
Conclusions: By using Barricor™ tubes and prompt centrifugation, supplemental analysis or re-analysis for eight analytes including alanine ami-
notransferase, alkaline phosphatase, C-reactive protein, high sensitivity troponin T, lactate dehydrogenase, NT-pro BNP, potassium and sodium could 
be performed within 72 h of specimen collection.
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Introduction
Many clinical laboratories for routine analytes have 
been using plasma or serum separator tubes for 
several years. The barrier gel allows rapid separa-
tion of serum or plasma from blood cells and re-
duces haemolysis. The gel used in these tubes is 
relatively inert, however several reports of gel af-
fecting analyte concentrations have been pub-
lished (1,2). 
Becton, Dickinson and Company (BD) has recently 
developed the BD Barricor™ plasma blood collec-
tion tube, which has a mechanical separator, rather 
than a gel barrier. According to the manufacturer, 
the quality of plasma is improved, the centrifuga-
tion time is shorter (3 min vs. 10 min with BD Vacu-
tainer® lithium heparin tubes) and post centrifuga-
tion analyte concentrations are more stable in sam-
ples that have been stored in the primary tube. At 
this time, some studies have been published to ver-
ify if these tubes are an effective alternative to gel 
barrier tubes (3-5). Nevertheless, these publications 
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concern mainly the correlations between results 
obtained using different tubes for biochemical pa-
rameters, particularly cardiac markers, without sta-
bility studies (3,4). The one study which has investi-
gated different storage conditions relates only to 
electrolytes (5). Given this lack of data, we aimed to 
compare results for nine biochemical tests from the 
BD Vacutainer® lithium heparin tubes vs. the BD 
Barricor™ plasma tubes and to determine plasma 
stability of analytes after centrifugation according 
to our routine laboratory practice. 
Materials and methods 
Subjects, blood sampling and analysis
Six healthy volunteers (physicians) and nine pa-
tients from intensive care units (Lapeyronie Hospi-
tal, Montpellier) were included in the study group. 
Healthy volunteers as well as hospitalized patients 
were selected to cover both normal and patholog-
ical analyte levels. All the samples were obtained 
in the morning between 8 and 9 am after over-
night fasting for healthy volunteers. The study was 
performed at Lapeyronie Hospital, Montpellier in 
June 2017, with appropriate ethics approval and 
with informed consent from all subjects. Two 
blood samples were drawn from each participant: 
one was collected into a 6 mL plastic BD Vacutain-
er® lithium heparin tube and the other into a 5.5 
mL plastic BD Barricor™ plasma tube (Becton, Dick-
inson and Company, Franklin Lakes, NJ, USA). Both 
types of tubes were transported to the laboratory 
and centrifuged without automated pre-analytical 
system within 30 min after venipuncture at 20 °C 
in a dedicated Heraeus Multifuge X3 FR Centrifuge 
(Germany) according to the manufacturer’s recom-
mendations (2000 x g for 10 min for lithium hepa-
rin tubes; 4000 x g for 3 min for Barricor™ plasma 
tubes). Thereafter, tubes were loaded on biochem-
istry analyser defining the time T0. Nine routine 
chemistry parameters were measured: alanine 
aminotransferase (ALT), alkaline phosphatase 
(ALP), aspartate aminotransferase (AST), C-reactive 
protein (CRP), high sensitivity troponin T (hs-cTnT), 
lactate dehydrogenase (LD), N-terminal pro brain 
natriuretic peptide (NT-pro BNP), potassium (K) 
and sodium (Na). All these biochemical analytes 
were quantified on a Cobas 8000© system includ-
ing c701 and c502 module (for biochemical analyt-
es) and e602 module (for immunoassays) from 
Roche Diagnostics (Meylan, France) using Roche 
reagent kits and calibrators. After the first analysis 
(T0), primary tubes were stored at + 4 °C according 
to our routine daily storage condition and re-ana-
lyzed at different time intervals (after 4, 24 and 72 
h). The 72 h deadline was chosen because it corre-
sponds to our daily practice. The visual appear-
ance of the two types of tube at each analysis time 
was monitored.
Statistical analysis
First, Passing-Bablok regression analysis was used 
to compare results from lithium heparin tubes 
with Barricor™ tubes for each analyte. The slopes 
and the intercepts were considered non-signifi-
cant when the 1 or 0 values fell within the 95% CI, 
respectively. Mann Whitney U-tests were used and 
the level of significance was set at P < 0.05. In addi-
tion, the scatter of differences was visualized by 
means of Bland-Altman plots and the calculated 
mean bias was reported for each analyte. Further, 
95% confidence intervals (mean difference ± 1.96 
SD) were reported to judge if biases are accept-
able in medical practice. In addition, the bias was 
calculated for each analyte by the formula: [(aver-
age of Barricor results – average of standard lithi-
um heparin results / average of standard lithium 
heparin results)] x 100. This percentage was com-
pared with the desirable bias available from Ricos 
et al. based on biological variation for nine param-
eters (6). 
For each storage time and for each analyte, the ab-
solute difference of each sample (or percentage 
deviation) against the T0 concentration was calcu-
lated for the two types of tubes using the formula: 
[(Tx - T0Ref) / T0Ref] x 100. The mean percentage de-
viation (± SD) of the fifteen donors was calculated 
for the two types of tube. To assess the stability of 
analytes, we calculated total change limit (TCL) as 
described by Oddoze et al. by using the formula: 
[(2.77 x CVa)² + (0.5 x CVb)²]½  where CVa is analyti-
cal imprecision and CVb is within-subject variation 
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(7). If mean percentage deviation (± SD) was high-
er than TCL value calculated for an analyte, then 
the analyte was considered not stable at + 4 °C for 
that length of storage. Statistical analyses were 
performed using XLSTAT® software, version 
2016.06.35661 (NY, USA). 
Results 
Results comparison at T0
Table 1 shows the regression analysis results of the 
values for the nine analytes obtained from regular 
lithium heparin tubes vs the values from Barricor™ 
lithium heparin tubes. The majority of correlation 
coefficients were close to 0.99 (ranging from 0.98 
to 1.00). We observed a slopes homogeneity (0.99 
to 1.03) as well as intercepts (- 1.5 to 3.74). No dif-
ference in the median concentrations for the nine 
analytes was detected. The concentrations were of 
the same order of magnitude. However, a slight 
over-estimation was observed for Na values with 
Barricor™ tube (the zero value of intercept did not 
fall within the 95% CI). Overall, Bland-Altman anal-
yses demonstrated an acceptable clinical concor-
dance for all analytes between the two different 
tubes with a maximum mean difference of - 6.87% 
(95% CI: 42.02 to -89.23) for LD. All results of the 
nine biochemical parameters from Barricor™ tube 
(ALT, ALP, AST, CRP, hs-cTnT, LD, NT-pro BNP, K, and 
Na) were not statistically different from results of 
standard lithium heparin tube. For the eight ana-
lytes the calculated bias was inside the maximum 
desirable bias. However, the calculated bias value 
for Na exceeded the value of desirable bias, al-
though minimally  (0.44% vs. 0.23%, respectively). 
The Na values between the two types of tubes 
were strongly correlated as observed with Passing 
Bablok regression. According to Bland-Altman 
plots (Figure 1), only one paired results was out-
side the limit of agreement. 
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ALT, U/L 7 - 65 1.00 (0.97 to 1.05)
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(- 3.50 – 1.89) - 0.7 11.5 0.933
ALP, U/L 26 - 401 1.02(1.00 to 1.06)
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(- 10.07 - 4.06) 0.9 6.7 0.983
AST, U/L 12 - 50 1.03(0.91 to - 1.16)
- 1.5






(- 7.176 - 4.06) - 1.3 6.5 0.819
CRP, mg/L 0.3 - 183 0.99(0.95 to 1.03)
0.00






(- 18.50 - 10.04) - 3.8 25.5 0.917
hs-TnT, ng/L 3 - 159 0.99(0.97 to 1.03)
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(- 11.84 - 6.35) - 0.8 23.7 0.932
LD, U/L 137 - 475 1.01(0.60 to 1.42)
3.74






(- 89.23 - 42.02) 3.2 4.3 1.000
NT-proBNP, 










(- 163.54 - 84.64) 0.9 4.7 0.917
K, mmol/L 3.4 - 4.9 1.00(0.92 to 1.14)
0.00






(- 0.29 - 0.16) - 0.5 1.8 0.630








(- 2.92 - 1.18) 0.4 0.2 0.570
ALT - alanine aminotransferase. AST - aspartate aminotransferase. CRP - C-reactive protein. LD - lactate dehydrogenase.  ALP -alkaline 
phosphatase. hs-cTnT - high sensitivity troponin T. NT-proBNP -  N-terminal prohormone of brain natriuretic peptide. K – potassium. 
Na – sodium. CI - confidence intervals. Values of biochemical analytes tested are given as median and interquartile range. P < 0.05 is 
considered statistically significant. *95% confidence intervals were calculated by the mean difference ± 1.96 SD.
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Table 2. Stability of plasma biochemical analytes stored over time in primary tubes tested
Analyte stability over time
Table 2 summarizes the results for all plasma ana-
lytes and the mean differences at several storage 
times at + 4 °C for both regular lithium heparin 
and Barricor™ lithium heparin primary tubes. Us-
ing TCL as the measure of acceptability, the mean 
difference exceeded the TCL after 4 h for K and LD 
in lithium heparin tube samples. In contrast, these 
two analytes were stable for 72 h using Barricor™ 
plasma tubes. For both types of tube, AST was 
only stable up to 24 h. After longer storage (mea-
surement at 72 h), AST increased for 11.96% and 
12.37%, exceeding the acceptable TCL. Excluding 
AST, there were only negligible changes in the 
plasma concentration of all the other analytes up 
to 72 h for Barricor™ lithium heparin tube samples. 
Discussion 
The correlation and the agreement in the working 
range of Barricor™ lithium heparin tube results 
with those of the regular lithium heparin tube 
were acceptable as seen by the regression and the 
BD lithium heparin tubes
Analyte TCL (%)
Mean % difference at + 4 °C 
Acceptable delay
T4h T24h T72h
ALT, U/L ± 21.75 6.02 (6.74) 4.04 (9.86) 1.40 (6.34) 72 h
ALP, U/L ± 14.34 - 0.47 (1.78) - 0.86 (1.87) - 1.13 (2.49) 72 h
AST, U/L ± 10.83 7.45 (7.03) 4.40 (8.27) 11.96 (7.60) 24 h
CRP, mg/L ± 38.72 - 4.96 (12.46) - 1.22 (12.70) - 3.97 (12.70) 72 h
hs-TnT, ng/L ± 9.37 - 0.01 (5.15) - 0.77 (2.45) 5.78 (20.20) 72 h
LD, U/L ± 8.82 7.84 (8.13) 10.19 (11.06) 15.98 (16.08) 4 h
NT-proBNP, ng/L ± 18.35 0.52 (2.00) 2.25 (3.10) - 6.37 (7.28) 72 h
K, mmol/L ± 6.21 0.51 (1.07) 12.29 (7.12) 53.39 (26.72) 4 h
Na, mmol/L ± 3.64 0.72 (0.47) 1.25 (0.88) 0.34 (0.53) 72 h
BD Barricor lithium heparin tubes
Analyte TCL (%)
Mean % difference at + 4 °C
Acceptable delay
T4h T24h T72h
ALT, U/L ± 21.75 2.39 (8.57) - 1.59 (7.97) 1.98 (10.64) 72 h
ALP, U/L ± 14.34 - 1.42 (2.50) - 0.93 (2.90) - 1.74 (3.36) 72 h
AST, U/L ± 10.83 4.36 (11.14) 5.60 (11.05) 12.37 (14.07) 24 h
CRP, mg/L ± 38.72 - 1.73 (2.96) 2.14 (3.52) - 0.49 (5.53) 72 h
hs-TnT, ng/L ± 9.37 0.72 (9.03) 2.27 (9.28) 6.00 (17.13) 72 h
LD, U/L ± 8.82 2.96 (3.96) 4.67 (4.13) 8.31 (10.22) 72 h
NT-proBNP, ng/L ± 18.35 - 0.78 (2.27) 0.33 (3.22) - 7.72 (7.32) 72 h
K, mmol/L ± 6.21 1.16 (1.30) 1.88 (1.18) 4.90 (1.92) 72 h
Na, mmol/L ± 3.64 0.00 (0.53) 0.52 (0.50) 1.00 (0.45) 72 h
ALT - alanine aminotransferase.  AST - aspartate aminotransferase. CRP - C-reactive protein. LD - lactate dehydrogenase.  ALP 
-alkaline phosphatase. hs-cTnT - high sensitivity troponin T. NT-proBNP - N-terminal prohormone of brain natriuretic peptide. K 
– potassium. Na – sodium. TCL - total change limit. SD – standard deviation. T4h, T24h, T72h – storage times in hours. Mean % 
differences are presented as mean (standard deviation).
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Figure 1. Bland-Altman difference plots for the nine 
biochemical analytes obtained with BD lithium heparin 
tubes and BD Barricor™ plasma tubes. 
The solid line shows the average of the differences ob-
tained and corresponds to the bias between results ob-
tained with two types of tubes. The dashed lines corre-
spond to the lower and upper limits of the confidence 
interval at 95% (mean ± 1.96 SD) of the difference be-
tween results obtained with two types of tubes. ALT - 
alanine aminotransferase. AST - aspartate aminotrans-
ferase. CRP - C-reactive protein. LD - lactate dehydroge-
nase. ALP - alkaline phosphatase. hs-cTnT - high sensitiv-
ity troponin T. NT-proBNP - N-terminal prohormone of 
brain natriuretic peptide. 
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Bland-Altman analysis with the majority of paired 
data within the agreement limits. However, Na 
concentrations in Barricor™ plasma tube tend to 
be higher than Na in regular lithium heparin tube. 
Since the analytical method is the same for both 
types of tubes, this might be explained with differ-
ent acceleration during centrifugation process be-
tween kinds of tubes. The biological variation for 
sodium is very small (0.23%) and the calculated 
bias is close to the desirable bias (0.44%); for these 
reasons, we considered that the observed differ-
ences were not clinically relevant and results re-
mained in normal range. Those data indicate that 
the use of Barricor™ tubes did not affect the con-
centrations of the nine analytes suggesting that 
Barricor™ tubes may be used interchangeably with 
regular lithium heparin tubes.
Further, we reported that concentrations for eight 
analytes remained stable up to 72 h in Barricor™ 
plasma tube, while AST activity increased signifi-
cantly after 24 h whatever the type of tubes. Clear-
ly, the Barricor™ plasma tubes improve post cen-
trifugation stability in comparison with BD Vacu-
tainer® lithium heparin, particularly for parameters 
sensible such as K and LD. 
This study confirms the manufacturer’s claims con-
cerning the visual quality of plasma, the shorter 
centrifugation time, which does not affect the 
concentrations of analytes, and the longer stability 
of analytes in samples stored post centrifugation 
in the primary Barricor™ lithium heparin tube. 
Therefore, supplemental analysis or re-analysis 
could be performed within 72 h of specimen col-
lection for eight analytes (except AST) with Barri-
cor™ lithium heparin tube samples.
The main limitation of our study is the number of 
samples available, but the recruitment of patho-
logical subjects allowed the evaluation of values 
covering a large measurement range. The small 
number of samples evaluated could also explain 
the differences observed between the 2 types of 
tubes for the results of Na. In previous studies, re-
sults obtained from Barricor™ tubes were com-
pared to plasma separator tube (PST) or serum 
with (SST) or without gel barrier (3-6). More recent-
ly, concentrations of analytes from PST, SST and 
Barricor™ tubes were compared according to dif-
ferent centrifugation conditions (8). In this context, 
our study provides additional data since it was 
performed with analytes not previously investigat-
ed with Barricor™ tube in comparison with lithium 
heparin tube and for which post centrifugation 
stability was evaluated. In addition, further work 
would be required to evaluate these new tubes on 
other analytical platforms to assess if the mechani-
cal separator affects the concentrations of other 
biochemical analytes and particularly the concen-
trations of therapeutic drugs as previously de-
scribed for BD SST tubes (9,10). The improvement 
of analytes stability is a capital data in regard with 
increasing trends in the field of biochemistry to-
wards the consolidation of testing laboratories us-
ing platforms that are more and more automated. 
By using Barricor™ lithium heparin tubes, which of-
fer increased post centrifugation stability of ana-
lytes, we foresee that, if the centrifugation is car-
ried out quickly after sampling and the tubes are 
stored at + 4 °C, primary tubes could be transport-
ed to the central laboratory and analysed at least 
up to 24 h post centrifugation.
In conclusion, at initial measure, the two different 
tube types are interchangeable for the nine ana-
lytes investigated on Roche platform. Our data 
demonstrated that the great advantage of these 
tubes is the stability of analytes after centrifuga-
tion during 72 h, allowing re-analyses or additional 
analyses if necessary for eight out of 9 measured 
analytes. Except for AST, analytes including ALT, 
ALP, CRP, hs-cTnT, LDH, NT-pro BNP, K and Na  were 
unaffected when stored at + 4 °C for up 72 h after 
centrifugation. 
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